Spyre Therapeutics, Inc.

Spyre Therapeutics is a biotech company developing medicines for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, and for rheumatic diseases like arthritis. The company is testing several experimental drugs made from antibodies, which are proteins that help the immune system fight disease. Its lead candidate is designed to reduce the inflammation that damages the digestive tract in IBD patients. Spyre is also exploring combination drugs that use multiple antibodies to attack different parts of the disease process.